PALLIATIVE TREATMENT OF DYSPHAGIA: FAILURES AND COMPLICATIONS
https://doi.org/10.21294/1814-4861-2017-16-1-76-81
Abstract
Background. Dysphagia is the main clinical symptom in patients with locally advanced esophageal carcinoma and proximal part of the stomach. Esophageal stenting is a highly effective and safe method to restore esophageal lumen patency. Published data indicate a high rate of stent-related complications. Material and methods. A retrospective, two-centered study included 166 patients (102 males and 64 females), who underwent endoscopically-guided esophageal stenting from 2004 to 2015. The age of the patients ranged from 36 to 92 years. Expandable metal stents were used for all patients. In most cases (81.3%), drug-eluting stents (22 mm diameter, 120 mm length) were preferable. Treatment outcomes and complications were analyzed. Results. Complications during stent placement (incorrect stent disclosure) were observed in 7 patients. All these complications were eliminated by relocating the stent to the desired position. Postoperative complications were noted in 29 patients (stent migration in 9 patients, stent fracture and migration in 2 patients, stent obstruction in 1 patient, destruction of stent coating and fragmentation in 5 patients, and dysphagia recurrence due to continuing tumor growth in 11 patients). All stent-related complications were corrected by re-endoscopy. Conclusions. The data obtained indicate the need for lifelong surveillance of patients after stenting.
About the Authors
E. A. Drobyazgin
Novosibirsk State Medical University, Novosibirsk
Russian Federation
Russian Federation
MD, Professor, Department of Hospital and Pediatric Surgery, Novosibirsk State Medical University; Leading Researcher, Oncology and Radiotherapy Department, E.N. Meshalkin Siberian Biomedical Research Center
SPIN-code: 4665-2278
Yu. V. Chikinev
Novosibirsk State Medical University, Novosibirsk
E.N. Meshalkin Siberian Biomedical Research Center, Ministry of Health Russian Federation, Center of Oncology and Radiotherapy, Novosibirsk
Russian Federation
Russian Federation
MD, Professor, Head of the Department of Hospital and Pediatric Surgery
SPIN-code: 9782-1047
A. A. Zheravin
E.N. Meshalkin Siberian Biomedical Research Center, Ministry of Health Russian Federation, Center of Oncology and Radiotherapy, Novosibirsk
Russian Federation
Russian Federation
MD, PhD, Head of Oncology and Radiotherapy Department, E.N. Meshalkin Siberian Biomedical Research Center
SPIN-code: 2858-7175
A. S. Kudryavtsev
E.N. Meshalkin Siberian Biomedical Research Center, Ministry of Health Russian Federation, Center of Oncology and Radiotherapy, Novosibirsk
Russian Federation
MD, surgeon-oncologist, Oncology and Radiotherapy Department, E.N. Meshalkin Siberian Biomedical Research Center
Russian Federation
MD, surgeon-oncologist, Oncology and Radiotherapy Department, E.N. Meshalkin Siberian Biomedical Research Center
References
1. Khrustaleva M.V., Godzhello E.A. The choice of the method of endoscopiс self-expandable stent placement for blastomatous lesions of the esophagus, cardia and esophageal anastomosis. Journal of Surgical Gastroenterology. 2011; 2: 14–26. [in Russian]
2. Pavlov P.V., Sokolov V.V., Pirogov S.S., Karpova E.S., Pogorelov N.N., Sukhin D.G. Endoscopic stenting of tumor stenosis of cervical part of esophagus. Experimental Clinical Gastroenterology. 2014; 3: 67–71. [in Russian]
3. Afanasyev S.G., Avgustinovich A.V., Tuzikov S.A., Pak A.V., Volkov M.Yu., Savel’ev I.N., Frolova I.G. Results of combined operations for locally advanced gastric cancer. Onkologija. Zhurnal im. P.A. Gercena. 2013; 2: 12–15. [in Russian]
4. Cheremisina O.V., Vusik M.V., Soldatov A.N., Reyner I.V. Modern possibilities of endoscopic laser technologies in clinical oncology. Siberian Journal of Oncology. 2017; 4: 5–11. [in Russian]
5. Balázs A., Kokas P., Lukovich P., Kupcsulik P. Palliative management of malignant oesophageal strictures with endoprosthesis implantation – 25 years experience. Magy Seb. 2011 Dec; 64 (6): 267–76. doi: 10.1556/ MaSeb.64.2011.6.1.
6. Goenka M.K., White R.E. Esophageal stenting in cancer therapy. Ann N Y Acad Sci. 2014 Sep; 1325: 89–95. doi: 10.1111/nyas.12525.
7. Freeman R.K., Ascioti A.J., Mahidhara R.J. Palliative therapy for patients with unresectable esophageal carcinoma. Surg Clin North Am. 2012 Oct; 92 (5): 1337–51. doi: 10.1016/j.suc.2012.07.004.
8. Martinez J.C., Puc M.M., Quiros R.M. Esophageal stenting in the setting of malignancy. ISRN Gastroenterol. 2011; 2011: 719575. doi: 10.5402/2011/719575.
9. Bjerring O.S., Pless T., Fristrup C., Mortensen M.B. Acceptable results after selfexpanding metallic stent treatment for dysphagia in nonresectable oesophageal cancer. Dan Med J. 2012 Jun; 59 (6): A4459.
10. Kusano-Kitazume A., Ami K., Nagahama T., Okamoto E., Tamura A., Takagi K., Hayasaka J., Watanabe A., Kawai Y., Fujiya K., Amagasa H., Ganno H., Imai K., Fukuda A., Ando M., Arai K., Shibayama T. Selfexpanding antireflux stents for malignant esophageal stenosis – a report of three cases. Gan To Kagaku Ryoho. 2014 Nov; 41 (12): 1988–90.
11. Mangiavillano B., Pagano N., Arena M., Miraglia S., Consolo P., Iabichino G., Virgilio C., Luigiano C. Role of stenting in gastrointestinal benign and malignant diseases. World J Gastrointest Endosc. 2015 May 16; 7 (5): 460–80. doi: 10.4253/wjge.v7.i5.460.
12. Mougey A., Adler D.G. Esophageal stenting for the palliation of malignant dysphagia. J Support Oncol. 2008 Jul-Aug; 6 (6): 267–73.
13. Nathwani R.A., Kowalski T. Endoscopic stenting of esophageal cancer: the clinical impact. Curr Opin Gastroenterol. 2007 Sep; 23 (5): 535–8. doi: 10.1097/MOG.0b013e3282a56968.
14. Diamantis G., Scarpa M., Bocus P., Realdon S., Castoro C., Ancona E., Battaglia G. Quality of life in patients with esophageal stenting for the palliation of malignant dysphagia. World J Gastroenterol. 2011 Jan 14; 17(2): 144 50. doi: 10.3748/wjg.v17.i2.144.
15. Konosu M., Kimura Y., Iwaya T., Akiyama Y., Fujiwara H., Endo F., Sugitachi A., Nishizuka S., Nitta H., Otsuka K., Kashiwaba M., Koeda K., Sasaki A., Mizuno M., Wakabayashi G. Usefulness of esophageal stenting for esophagorespiratory fistula with esophageal cancer. Gan To Kagaku Ryoho. 2012 Nov; 39 (12): 1849–51.
16. Rueth N.M., Shaw D., D’Cunha J., Cho C., Maddaus M.A., Andrade R.S. Esophageal stenting and radiotherapy: a multimodal approach for the palliation of symptomatic malignant dysphagia. Ann Surg Oncol. 2012 Dec; 19 (13): 4223–8. doi: 10.1245/s10434-012-2459-3.
17. Bergquist H., Wenger U., Johnsson E., Nyman J., Ejnell H., Hammerlid E., Lundell L., Ruth M. Stent insertion or endoluminal brachytherapy as palliation of patients with advanced cancer of the esophagus and gastroesophageal junction. Results of a randomized, controlled clinical trial. Dis Esophagus. 2005; 18 (3): 131–9. doi: 10.1111/j.1442-2050. 2005.00467.x.
18. Mariette C., Piessen G., Triboulet J.P. Therapeutic strategies in oesophageal carcinoma: role of surgery and other modalities. Lancet Oncol. 2007 Jun; 8 (6): 545–53. doi: 10.1016/S1470-2045(07)70172-9.
19. Motilall S.R., Modiba M.C., Tsatsi L.D., Becker P.J. Trial of selfexpandable metallic stents in the palliation of tracheo-oesophageal fistula in carcinoma of the oesophagus. S Afr J Surg. 2007 Feb; 45 (1): 24–7.
20. Smolyar A.N., Radchenko Yu.A., Nefedova G.A. Complications of esophageal stenting. Surgery. 2014; 12: 29–35. [in Russian]
21. Harries R., Campbell J., Ghosh S. Fractured migrated oesophageal stent fragment presenting as small bowel obstruction three years after insertion. Ann R Coll Surg Engl. 2010 Sep; 92 6): W14–5. doi: 10.1308/ 147870810X12699662981078.
22. Martins B.C., Retes F.A., Medrado B.F., de Lima M.S., Pennacchi C.M., Kawaguti F.S., Safatle-Ribeiro A.V., Uemura R.S., Maluf-Filho F.Endoscopic management and prevention of migrated esophageal stents. World J Gastrointest Endosc. 2014 Feb 16; 6 (2): 49–54. doi: 10.4253/ wjge.v6.i2.49.
23. Oh S.J., Song H.Y., Nam D.H., Ko H.K., Park J.H., Na H.K., Lee J.J., Kang M.K. Bleeding after expandable nitinol stent placement in patients with esophageal and upper gastrointestinal obstruction: incidence, management, and predictors. Acta Radiol. 2014 Nov; 55 (9): 1069–75. doi: 10.1177/0284185113511080.
24. Park J.H., Song H.Y., Shin J.H., Cho Y.C., Kim J.H., Kim S.H., Park J. Migration of retrievable expandable metallic stents inserted for malignant esophageal strictures: incidence, management, and prognostic factors in 332 patients. AJR Am J Roentgenol. 2015 May; 204 (5): 1109–14. doi: 10.2214/AJR.14.13172.
Review
For citations:
Drobyazgin E.A., Chikinev Yu.V., Zheravin A.A., Kudryavtsev A.S. PALLIATIVE TREATMENT OF DYSPHAGIA: FAILURES AND COMPLICATIONS. Siberian journal of oncology. 2017;16(1):76-81. (In Russ.) https://doi.org/10.21294/1814-4861-2017-16-1-76-81
Views:
2076
Email this article 
